By Sally Robertson, B.Sc Researchers in India have conducted a meta-analysis investigating the effects of using angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) on outcomes among patients with COVID-19. They say their data suggest that continuing these treatments among this patient group is not only safe but significantly reduces the risk of severe...
Tag: <span>ACE inhibitors</span>
Post
ACE inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER New Orleans, LA – James Diaz, MD, MHA, MPH & TM, Dr PH, Professor and Head of Environmental Health Sciences at LSU Health New Orleans School of Public Health, has proposed a possible explanation for the severe lung complications being seen in some people diagnosed with COVID-19. The manuscript...